Great discussions at OIS Retina Innovation Summit on the future of regenerative medicine. CEO @drsmusunuri joined fellow experts to discuss #genetherapy and Ocugen's late-stage pipeline, including #OCU400 for RP, #OCU410ST for Stargardt disease, and #OCU410 for GA. @OISTWEETS
Meaningful partnerships and innovative thinking will be critical to ensuring that scientific advances reach the patients who need them most. It was a pleasure to host Connie at Ocugen and discuss opportunities to expand patient access globally.
Connie Collingsworth, Member of our Business Advisory Board and former COO of the @gatesfoundation, met with CEO @drsmusunuri this week to discuss global access partnerships as we work to advance transformative modifier gene therapies for patients around the world. #GlobalHealth
#OCUGEN Approved names for the initial marketing of two of the three gene therapies; we've gone from scientific to commercial names.π
ΒΏLotes de OCU400 LISTOS?π§π€π€«
#LETSGOOO
FYSTARZI= #OCU410ST
LYTSTARIQ= #OCU400